News + Filings Transactions
|
Peterson Amy C.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/24/2023 | EXELIXIS, INC. | EXEL | Grant | | 240k | $0.00 | $0 | | 08/24/2023 |
| 08/24/2023 | EXELIXIS, INC. | EXEL | Grant | Option (right to buy) | 160k | $21.75 | $3.5M | | 08/24/2023 |
| 03/16/2023 | CytomX Therapeutics, Inc. | CTMX | Sale | Common Stock | 4.3k | $1.98 | $8.4k | | 03/16/2023 |
| 07/20/2022 | CytomX Therapeutics, Inc. | CTMX | Sale | Common Stock | 7.5k | $1.42 | $10.6k | | 07/19/2022 |
| 07/19/2022 | CytomX Therapeutics, Inc. | CTMX | Grant | Common Stock | 20k | $0.00 | $0 | | 07/19/2022 |
| 02/02/2022 | CytomX Therapeutics, Inc. | CTMX | Grant | Common Stock | 40k | $0.00 | $0 | | 02/02/2022 |
| 02/02/2022 | CytomX Therapeutics, Inc. | CTMX | Grant | Stock Option (Right to Buy) | 200k | $4.13 | $826k | | 02/02/2022 |
| 10/24/2021 | CytomX Therapeutics, Inc. | CTMX | Grant | Performance Stock Units (PSUs) | 40k | $0.00 | $0 | | 10/24/2021 |
| 10/24/2021 | CytomX Therapeutics, Inc. | CTMX | Grant | Stock Option (Right to Buy) | 50k | $5.34 | $267k | | 10/24/2021 |
| 05/31/2021 | CytomX Therapeutics, Inc. | CTMX | Grant | Common Stock | 3.3k | $6.09 | $20.2k | | 05/31/2021 |
| 02/26/2021 | CytomX Therapeutics, Inc. | CTMX | Grant | Stock Option (right to buy) | 250k | $7.85 | $2M | | 02/26/2021 |
| 11/30/2020 | CytomX Therapeutics, Inc. | CTMX | Grant | Common Stock | 3.1k | $6.39 | $19.8k | | 11/30/2020 |
| 02/14/2020 | CytomX Therapeutics, Inc. | CTMX | Grant | Stock Option (right to buy) | 25k | $7.13 | $178.2k | | 02/14/2020 |
| 10/15/2019 | CytomX Therapeutics, Inc. | CTMX | Grant | Stock Option (Right to Buy) | 400k | $7.16 | $2.9M | | 10/15/2019 |
| 12/18/2018 | BeiGene, Ltd. | BGNE | Exercise | Share Option (Right to Buy) | 131.8k | $0.00 | $0 | | 12/17/2018 |
| 12/18/2018 | BeiGene, Ltd. | BGNE | Exercise | | 10.1k | $29.10 | $295.1k | | 12/17/2018 |
| 12/18/2018 | BeiGene, Ltd. | BGNE | Sale | | 1.6k | $131.74 | $214.9k | | 12/17/2018 |
| 12/18/2018 | BeiGene, Ltd. | BGNE | Sale | | 1.9k | $132.70 | $251.7k | | 12/17/2018 |
| 12/18/2018 | BeiGene, Ltd. | BGNE | Sale | | 2.4k | $133.88 | $321.6k | | 12/17/2018 |
| 12/18/2018 | BeiGene, Ltd. | BGNE | Sale | | 3.6k | $134.81 | $485.3k | | 12/17/2018 |
| 12/18/2018 | BeiGene, Ltd. | BGNE | Sale | | 611 | $135.54 | $82.8k | | 12/17/2018 |
| 12/17/2018 | BeiGene, Ltd. | BGNE | Exercise | Share Option (Right to Buy) | 128.2k | $0.00 | $0 | | 12/17/2018 |
| 12/17/2018 | BeiGene, Ltd. | BGNE | Exercise | | 9.9k | $29.10 | $286.9k | | 12/17/2018 |
| 12/17/2018 | BeiGene, Ltd. | BGNE | Sale | | 900 | $130.37 | $117.3k | | 12/17/2018 |
| 12/17/2018 | BeiGene, Ltd. | BGNE | Sale | | 2.7k | $131.80 | $355.9k | | 12/17/2018 |
| 12/17/2018 | BeiGene, Ltd. | BGNE | Sale | | 1.7k | $132.91 | $226k | | 12/17/2018 |
| 12/17/2018 | BeiGene, Ltd. | BGNE | Sale | | 1k | $133.81 | $134.5k | | 12/17/2018 |
| 12/17/2018 | BeiGene, Ltd. | BGNE | Sale | | 778 | $135.04 | $105.1k | | 12/17/2018 |
| 12/17/2018 | BeiGene, Ltd. | BGNE | Sale | | 2.3k | $136.24 | $312.8k | | 12/17/2018 |
| 12/17/2018 | BeiGene, Ltd. | BGNE | Sale | | 480 | $136.93 | $65.7k | | 12/17/2018 |
| 11/12/2018 | BeiGene, Ltd. | BGNE | Sale | | 100 | $121.56 | $12.2k | | 11/08/2018 |
| 11/12/2018 | BeiGene, Ltd. | BGNE | Exercise | Share Option (Right to Buy) | 156.9k | $0.00 | $0 | | 11/08/2018 |
| 11/12/2018 | BeiGene, Ltd. | BGNE | Sale | | 4k | $112.18 | $448.7k | | 11/08/2018 |
| 11/12/2018 | BeiGene, Ltd. | BGNE | Sale | | 2.5k | $113.03 | $285.6k | | 11/08/2018 |
| 11/12/2018 | BeiGene, Ltd. | BGNE | Sale | | 1.2k | $113.92 | $133.6k | | 11/08/2018 |
|
|